Selling And Administration Expenses Cambiamento Data
AbbVie USD 3.61B 273M 2023-12
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Cipla INR 10.91B 245.2M 2023-09
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.29M 163K 2023-09
CSL USD 1.29B 219.4M 2023-06
Eisai JPY 92.79B 6.7B 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Grifols EUR 300.32M 28.7M 2023-09
Incyte USD 293.86M 25.97M 2023-12
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
J&J USD 5.81B 410M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Roche Holding CHF 6.51B 26M 2023-06
TG Therapeutics USD 31.15M 1.62M 2023-12
Vascular Biogenics USD 1.85M 1.39M 2023-09



Infinity Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.